NYSE · SOAP, DETERGENTS, CLEANG PREPARATIONS, PERFUMES, COSMETICS · LARGE CAP
Stepan Company SCL
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY15 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$2.3B
▲ 7.0% vs FY2024
Dividend streak
15 yrs
Raised every year since 2011
EPS · FY25
$2.05
Dividend / sh · FY25
$1.55
Payout · FY25
75%
ROE · FY25
3.9%
Net margin · FY25
2.0%
Dividend coverage
1.3×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 2.3B
Revenue, FY2025 · full 17-year series below
Revenue
Net income
2 cents of every revenue dollar became profit this year.
Per share
USD 2.05
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 1.3 times — the rest stayed in the company.
Profitability
3.9%
Return on equity, FY2025
ROE
Operating margin3.4%
Net margin2.0%
Return on assets2.0%
Each USD of equity produced 4 cents of profit this year.
Returned to shareholders
USD 35.0M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 35.0M
Net buybacks—
Share of profit74.7%
Consecutive raises15 years
USD 35.0M in dividends — 75% of the year's profit went back to shareholders.
Growth
+4.5% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−5.6%
+4.5%
+2.8%
+3.3%
Net income
−31.7%
−18.0%
−4.7%
−2.2%
EPS, diluted
−31.5%
−17.8%
−4.7%
−2.4%
Dividend / share
+4.2%
+6.5%
+7.8%
+8.0%
Returned to shareholders
−13.8%
−1.5%
+7.2%
+7.9%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 2.4B
total assets, end of FY2025
Total assetsUSD 2.4B
EquityUSD 1.2B
CashUSD 132.7M
Gross debtUSD 626.7M
Net debtUSD 494.0M
Current ratio1.29×
Net debt stands at 40% of equity.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
2.3
2.2
2.3
2.8
2.3
1.9
1.9
2.0
1.9
1.8
1.8
1.9
1.9
1.8
1.8
1.4
1.3
Operating income $B
0.1
0.1
0.1
0.2
0.2
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
EBITDA $B
0.2
0.2
0.2
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
EPS, diluted $
2.05
2.20
1.75
6.38
5.92
5.45
4.42
4.76
4.31
3.73
3.32
2.49
3.18
3.49
3.21
2.95
5.84
Dividend / sh $
1.55
1.51
1.47
1.37
1.25
1.13
1.03
0.93
0.86
0.78
0.73
0.69
0.65
0.58
0.53
0.49
0.90
Payout %
75
67
82
21
20
20
22
19
19
20
21
27
20
16
16
16
15
ROE %
3.9
4.2
3.4
13.1
13.4
13.5
12.1
14.4
14.7
14.5
13.9
10.5
14.1
18.0
19.2
18.7
·
Shares out B
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
66 of 66
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed